Aditya Parekh
Aditya Parekh
Postdoctoral scholar, NCBS, Bengaluru
Verified email at
Cited by
Cited by
Exosome as a novel shuttle for delivery of therapeutics across biological barriers
CK Das, BC Jena, I Banerjee, S Das, A Parekh, SK Bhutia, M Mandal
Molecular pharmaceutics 16 (1), 24-40, 2018
Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells
S Rajput, BNP Kumar, KK Dey, I Pal, A Parekh, M Mandal
Life sciences 93 (21), 783-790, 2013
Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer
CK Das, A Parekh, PK Parida, SK Bhutia, M Mandal
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1866 (6), 1004-1018, 2019
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
BNP Kumar, S Rajput, KK Dey, A Parekh, S Das, A Mazumdar, M Mandal
Bmc Cancer 13, 1-15, 2013
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ...
Oncogene 37 (33), 4546-4561, 2018
Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy
S Parida, C Maiti, Y Rajesh, KK Dey, I Pal, A Parekh, R Patra, D Dhara, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (1), 3039-3052, 2017
Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells
A Parekh, D Das, S Das, S Dhara, K Biswas, M Mandal, S Das
Scientific reports 8 (1), 783, 2018
Therapeutic implication of ‘Iturin A’for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion
G Dey, R Bharti, PK Ojha, I Pal, Y Rajesh, I Banerjee, P Banik, S Parida, ...
Cellular signalling 35, 24-36, 2017
GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling
S Parida, I Pal, A Parekh, B Thakur, R Bharti, S Das, M Mandal
Cell death & disease 7 (3), e2154-e2154, 2016
Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp.
SM Mandal, D Mahata, L Migliolo, A Parekh, PS Addy, M Mandal, A Basak
Journal of Biological Chemistry 289 (37), 25469-25473, 2014
Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach
KK Dey, I Pal, R Bharti, G Dey, BNP Kumar, S Rajput, A Parekh, S Parida, ...
Tumor Biology 36, 9829-9837, 2015
Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model
S Parida, A Parekh, G Dey, SC Ghosh, M Mandal
Cancer biology & therapy 16 (6), 922-932, 2015
Wavelet-based multiscale analysis of bioimpedance data measured by electric cell-substrate impedance sensing for classification of cancerous and normal cells
D Das, K Shiladitya, K Biswas, PK Dutta, A Parekh, M Mandal, S Das
Physical Review E 92 (6), 062702, 2015
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance
S Das, M Kundu, A Hassan, A Parekh, BC Jena, S Mundre, I Banerjee, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (6), 166702, 2023
Cancer stem cell induces chemoresistance in breast cancer via macrophage migration inhibitory factor mediated activation of AKT pathway
S Das, M Kundu, A Parekh, D Bharadwaj, M Mandal
Cancer Research 79 (13_Supplement), 4676-4676, 2019
Targeting ECM via stress associated regulation: A potential therapeutic avenue for overcoming temozolamide resistance in glioblastoma
A Biswas, R Yetirajam, S Das, A Parekh, M Mandal
New Biotechnology 44, S141-S142, 2018
Progressing towards a human-centric approach in cancer research
A Parekh, S Das, CK Das, M Mandal
Frontiers in Oncology 12, 896633, 2022
Polyploid giant cancer cells induce growth arrest and cytoskeletal rearrangement in breast cancer cells
D Bharadwaj, A Parekh, S Das, BC Jena, M Mandal
New Biotechnology 44, S141, 2018
Integrin β1 regulates doxorubicin resistance in breast cancer via FAK-mediated activation of ERK1 pathway
S Das, BC Jena, S Mundre, A Parekh, Y Rajesh, P Mitra, M Mandal
Cancer Research 78 (13_Supplement), 4022-4022, 2018
201 Combinatorial Effect of ZD6474 and Thymoquinone Inhibits Src Mediated ERK-1/2/STAT3 Signalling and Renders Antimetastasis in Breast Cancer
S Rajput, KK Dey, P Ipsita, K Sen, G Dey, R Bharti, S Parida, A Parekh, ...
European Journal of Cancer, 61, 2012
The system can't perform the operation now. Try again later.
Articles 1–20